Cargando…

Therapeutic efficacy and anti-inflammatory effect of ramelteon in patients with insomnia associated with lower urinary tract symptoms

OBJECTIVES: This study was conducted to examine the therapeutic efficacy and anti-inflammatory effect of ramelteon in elderly patients with insomnia associated with lower urinary tract symptoms (LUTS), who visited our urology department. METHODS: The study included 115 patients (102 men, 13 women) w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shimizu, Nobutaka, Nozawa, Masahiro, Sugimoto, Koichi, Yamamoto, Yutaka, Minami, Takafumi, Hayashi, Taiji, Yoshimura, Kazuhiro, Ishii, Tokumi, Uemura, Hirotsugu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826936/ https://www.ncbi.nlm.nih.gov/pubmed/24400242 http://dx.doi.org/10.2147/RRU.S44502

Ejemplares similares

Survey on lower urinary tract symptoms and sleep disorders in patients treated at urology departments
por: Shimizu, Nobutaka, et al.
Publicado: (2013)

Acotiamide hydrochloride hydrate added to combination treatment with an α-blocker and a cholinergic drug improved the QOL of women with acute urinary retention: case series
por: Sugimoto, Koichi, et al.
Publicado: (2017)

Procalcitonin as a useful marker to decide upon intervention for urinary tract infection
por: Sugimoto, Koichi, et al.
Publicado: (2013)

Critical appraisal of ramelteon in the treatment of insomnia
por: Mets, Monique AJ, et al.
Publicado: (2010)

Higher neutrophil-to-lymphocyte ratio after the first cycle of the first-line chemotherapy is associated with poor cancer specific survival of upper urinary tract carcinoma patients
por: Hashimoto, Mamoru, et al.
Publicado: (2021)

Pharmacotherapy of Insomnia with Ramelteon: Safety, Efficacy and Clinical Applications
por: Pandi-Perumal, Seithikurippu R., et al.
Publicado: (2011)

Evaluation of in vivo responses of sorafenib therapy in a preclinical mouse model of PTEN-deficient of prostate cancer
por: Yamamoto, Yutaka, et al.
Publicado: (2015)

A pilot study of acotiamide hydrochloride hydrate in patients with detrusor underactivity
por: Sugimoto, Koichi, et al.
Publicado: (2015)

Prognostic factors in Japanese men with high-Gleason metastatic castration-resistant prostate cancer
por: Nishimoto, Mitsuhisa, et al.
Publicado: (2022)

Comparison of molecular profiles of upper tract urothelial carcinoma vs. urinary bladder cancer in the era of targeted therapy: a narrative review
por: Tomiyama, Eisuke, et al.
Publicado: (2022)

Sarcopenia and Visceral Obesity are Significantly Related to Severe Storage Symptoms in Geriatric Female Patients
por: Hashimoto, Mamoru, et al.
Publicado: (2021)

Reactivation of latent tuberculosis infection induced by cabazitaxel in a patient with prostate cancer: A case report
por: Hashimoto, Mamoru, et al.
Publicado: (2019)

The Melatonin Receptor Agonist Ramelteon Effectively Treats Insomnia and Behavioral Symptoms in Autistic Disorder
por: Kawabe, Kentaro, et al.
Publicado: (2014)

A case of neuroendocrine tumor at the external urethral meatus after total cystectomy
por: Miki, Koji, et al.
Publicado: (2023)

Ramelteon for Delayed Sleep-wake Phase Disorder: A Case Report
por: Takeshima, Masahiro, et al.
Publicado: (2020)

Use of Melatonin and/on Ramelteon for the Treatment of Insomnia in Older Adults: A Systematic Review and Meta-Analysis
por: Marupuru, Srujitha, et al.
Publicado: (2022)

The Effects of Ramelteon on Glucose Metabolism and Sleep Quality in Type 2 Diabetic Patients With Insomnia: A Pilot Prospective Randomized Controlled Trial
por: Tsunoda, Tetsuji, et al.
Publicado: (2016)

Sequential therapy with darolutamide in patients with non‐metastatic castration‐resistant prostate cancer resistant to enzalutamide or apalutamide
por: Fujmoto, Saizo, et al.
Publicado: (2022)

A novel prediction model for the completion of six cycles of radium-223 treatment and survival in patients with metastatic castration-resistant prostate cancer
por: Miyoshi, Yasuhide, et al.
Publicado: (2021)

Prognosis and safety of radium‐223 with concurrent abiraterone acetate or enzalutamide use for metastatic castration‐resistant prostate cancer: Real‐world data of Japanese patients
por: Miyoshi, Yasuhide, et al.
Publicado: (2020)

Clinical outcome of incidentally discovered small renal cell carcinoma after delayed surgery
por: Sugimoto, Koichi, et al.
Publicado: (2013)

Clinical Outcome of Small Renal Cell Carcinoma after Delayed Surgery versus Immediate Surgery
por: Sugimoto, Koichi, et al.
Publicado: (2013)

Comparison of Abiraterone and Combined Androgen Blockade Therapy for High-Risk Metastatic Hormone-Sensitive Prostate Cancer: A Propensity Score-Matched Analysis
por: Matsumura, Naoki, et al.
Publicado: (2021)

A review of ramelteon in the treatment of sleep disorders
por: Neubauer, David N
Publicado: (2008)

Trop-2 in Upper Tract Urothelial Carcinoma
por: Tomiyama, Eisuke, et al.
Publicado: (2022)

Continuous or intermittent? On the dosing schedule of sunitinib for advanced renal cell carcinoma
por: Nozawa, Masahiro, et al.
Publicado: (2012)

Proposal of “cyclic therapy”, a novel treatment strategy with targeted agents for advanced renal cell carcinoma
por: Nozawa, Masahiro, et al.
Publicado: (2013)

Ramelteon combined with an α(1)-blocker decreases nocturia in men with benign prostatic hyperplasia
por: Kawahara, Takashi, et al.
Publicado: (2013)

Serious Hypokalemia Associated with Abiraterone Acetate in Patients with Castration-Resistant Prostate Cancer
por: Yamamoto, Yutaka, et al.
Publicado: (2018)

Residual effects of low dose of suvorexant, zolpidem, and ramelteon in healthy elderly subjects: A randomized double‐blind study
por: Uemura, Sachiko Ito, et al.
Publicado: (2022)

Postoperative delirium after pharyngolaryngectomy with esophagectomy: a role for ramelteon and suvorexant
por: Booka, Eisuke, et al.
Publicado: (2017)

Effects of Add-on Ramelteon on Cognitive Impairment in Patients with Schizophrenia: An Open-label Pilot Trial
por: Shirayama, Yukihiko, et al.
Publicado: (2014)

Evaluation of the Anxiolytic Effect of Ramelteon in Various Rat Models of Anxiety
por: Nachiappan, KR, et al.
Publicado: (2023)

Phase I clinical trial of human vascular endothelial growth factor receptor 1 peptide vaccines for patients with metastatic renal cell carcinoma
por: Yoshimura, K, et al.
Publicado: (2013)

Melatonin and Its Agonist Ramelteon in Alzheimer's Disease: Possible Therapeutic Value
por: Srinivasan, Venkatramanujam, et al.
Publicado: (2010)

The Relief Effects of Ramelteon on Refractory Chronic Migraine: A Case Report
por: Hou, Yi-Cheng, et al.
Publicado: (2016)

Ramelteon Reduces Oxidative Stress by Maintenance of Lipid Homeostasis in Porcine Oocytes
por: Sun, Jing-Tao, et al.
Publicado: (2022)

Molecular Mechanisms of Neurogenic Lower Urinary Tract Dysfunction after Spinal Cord Injury
por: Shimizu, Nobutaka, et al.
Publicado: (2023)

New Frontiers of Basic Science Research in Neurogenic Lower Urinary Tract Dysfunction
por: Miyazato, Minoru, et al.
Publicado: (2017)

Non‐24‐hour sleep‐wake disorder successfully treated with the combination of ramelteon and suvorexant in a case of autism spectrum disorder
por: Iwata, Masaaki, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_81kvdjj6j0bn80g6rn3kjtkqs0